We connect people with life-changing medicine across Europe.
Sciensus, a leading European life sciences organisation with over 30 years of experience, helps over 240,000 patients a year gain access to beneficial treatments and candidate therapies.
Turning real-world patient experiences into life-changing decisions
Behind every patient and their health journey is a real story – moments of progress, setbacks and choices that shape people’s health outcomes. At Sciensus, we transform these stories into actionable insights, revealing why patients disengage with their treatment, when to intervene to offer personalised support and how to keep them on track so they can enjoy life the way they want to.
By connecting these individual narratives, we can uncover patterns and predictive behaviour that empower pharmaceutical companies and biotechs with critical insights they wouldn’t otherwise have. These insights also enable healthcare professionals to optimise medications, refine treatment pathways and design smarter patient interventions to elevate the patient experience overall.
We serve over 240,000 patients a year through our team of over 700 licensed clinical staff and we partner with over 3,000 pharmacies and hospitals. Together, we’re not just improving patient outcomes, we’re reshaping the future of healthcare.
Patient access
Patient engagement
Actionable insights
Transforming insights into actions that change lives
We sit at the critical intersection of patients and their medicine, delivering tailored solutions across diverse therapeutic areas to drive deeper patient understanding, personalised treatments and improved adherence.
Cancer
We are Europe’s leading provider of at-home cancer care, providing systemic anti-cancer therapies for patients and personalised support through digital apps and remote monitoring.
Sciensus Digital+
Through advanced digital platforms and human-touch services, we leverage AI and machine learning to connect pharma to actionable insights about how patients interact with their medicine in real-world settings, transforming patient experiences.
Rare and orphan diseases
Our global network of experts and tailored end-to-end solutions are dedicated to helping biotechs get their rare and orphan medicines to hard-to-reach patients in Europe and beyond.
Long-term conditions
We meet the complex medical needs of 240,000 patients each year across 50 therapy areas. Our best-in-class digital apps gather real-world patient insights that help clinicians and pharma make faster, better – data-driven – decisions.
Expertise that makes the difference
With our clinical expertise, experience and insights, no one knows patients like we do.
0
drugs distributed per year
0
patient interactions
0
patients supported each year
0
patients active on our apps
As a strategic partner, they have exceeded our expectations by finding global patients, who need our drugs, and enabling them to receive their life-extending medications.
Chief Commercial Officer at leading US Biotech company
News and Insights
Stay up to date with the news and learn from our experts across Sciensus.
Blogs
Sciensus announces two new senior hires as it continues to grow as a leading European life sciences organisation
Sciensus, a leading European life sciences organisation, focused on accelerating patients’ access to lifesaving medicines, is pleased to announce that…
Case Studies
How Sciensus supported the launch of a breakthrough therapy in Europe
Overview Sciensus has more than 30 years’ experience supporting pharmaceutical companies with the launch and distribution of orphan drugs outside…
Thought Leadership
The impact of real-world data in gaining access to the European orphan drugs market.